Background and objective The management of symptoms in patients with advanced chronic
respiratory diseases needs more attention. This review summarizes the latest evidence on …

This paper is the thirty-ninth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2016 …

There is increased awareness of palliative care needs in people with chronic obstructive
pulmonary disease (COPD) or interstitial lung disease (ILD). This European Respiratory …

The absence or late initiation of palliative care (PC) in chronic obstructive pulmonary
disease (COPD) is multidimensional. To provide palliative care from the moment of COPD …

Introduction Chronic breathlessness is highly prevalent and distressing to patients and
families. No medication is registered for its symptomatic reduction. The strongest evidence is …

This study explored the approaches of respiratory and palliative medicine specialists to
managing the chronic breathlessness syndrome in patients with severe chronic obstructive …

Extract People with interstitial lung disease (ILD) often have persistent breathlessness that
worsens over months or years, despite optimal disease modifying therapies and non …

Introduction Regular, low-dose, sustained-release morphine is effective in reducing chronic
breathlessness in people with advanced disease, particularly in patients with chronic …

La publication des résultats de plusieurs essais randomisés de grande ampleur sur les
traitements pharmacologiques de la BPCO (nouvelles associations fixes, désescalade …

Chronic breathlessness, which may be better described as persistent breathlessness to
optimise applicability to different languages, is a frequent cause of disability in COPD [1]. In …